soul trial oral semaglutide cardiovascular outcomes 2024 nejm Heart disease is the #1 cause of death in type 2 diabetes — and for the first time, an GLP-1 drug has been proven to reduce major events The Oral Semaglutide and Cardiovascular Outcomes

Nutrient Gaps

Regulators have emphasized familiar compliance fundamentals in this context: clear disclosures of total cost and material terms, substantiation for typical results claims, and truthful, nonmanipulated testimonials and reviews with appropriate disclosure of material connections

A rare form of vision loss has been linked to certain GLP-1s, but more so to Wegovy than to other weight-loss drugs in this class

INFLAMMATION OF THE SCALP Do you have inflammation of the scalp

PlexusDx provides compounded semaglutide and tirzepatide injections with clear guidance to help you feel confident with every dose

Migraines can make sufferers lives a misery, with some left bedridden for days as they wait to recover